Literature DB >> 7829400

Inhibitory effect of oversulfated fucoidan on invasion through reconstituted basement membrane by murine Lewis lung carcinoma.

S Soeda1, S Ishida, H Shimeno, A Nagamatsu.   

Abstract

We investigated the effects of native, oversulfated, and desulfated fucoidans and heparin on the invasion of 3 LL cells through Matrigel. Of the four polysaccharides tested, oversulfated fucoidan was the most potent inhibitor of tumor cell invasion and inhibited most potently and specifically the tumor cell adhesion to laminin. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis of the binding of elastase-cleaved laminin to fucoidan- and heparin-Sepharoses showed that both polysaccharides bound to the 62 and 56 kDa fragments. Pretreatment of 3LL cells with native or oversulfated fucoidan reduced their adhesive potency to laminin. The two fucoidans inhibited further the laminin binding of 3 LL cells which had been pretreated with a laminin-based pentapeptide, YIGSR. These results suggest that fucoidan specifically binds to not only the heparin binding domain(s) of laminin but also site(s) other than the cell surface laminin receptor. 3 LL cells secreted a 50 kDa form of urokinase-type plasminogen activator (u-PA). The extracellular level of u-PA activity was increased 1.7 times by addition of laminin but not type IV collagen. Oversulfated fucoidan most potently reduced the increased u-PA levels. Therefore, the reduction in in vitro invasiveness of 3 LL cells in response to either fucoidan or its oversulfated derivative may result from an inhibition of physical interaction between the tumor cells and the Matrigel (laminin), followed by a suppression of the laminin-induced increase in extracellular u-PA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829400      PMCID: PMC5919365          DOI: 10.1111/j.1349-7006.1994.tb02920.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


sodium dodecyl sulfate polyacrylamide gel electrophoretic urokinase‐type plasminogen activator phosphate‐buffered saline PBWTween 20 Engelbreth‐Helm‐Swarm high‐power field bovine serum albumin enzyme‐linked immunosorbent assay Try‐Ile‐GlySer. Arg glutaryl‐glycyl‐L‐arginine 4‐methylcou‐maryl‐ ‘l‐amide 7.amino‐4.methylcoumarin
  21 in total

1.  Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells.

Authors:  I Saiki; J Murata; M Nakajima; S Tokura; I Azuma
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

Review 2.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

3.  Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.

Authors:  P Mignatti; E Robbins; D B Rifkin
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Binding of heparin on the surface of cultured human endothelial cells.

Authors:  B Glimelius; C Busch; M Höök
Journal:  Thromb Res       Date:  1978-05       Impact factor: 3.944

6.  YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation.

Authors:  Y Iwamoto; F A Robey; J Graf; M Sasaki; H K Kleinman; Y Yamada; G R Martin
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

Review 7.  Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.

Authors:  L A Liotta
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

8.  Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.

Authors:  J Inokuchi; M Jimbo; K Momosaki; H Shimeno; A Nagamatsu; N S Radin
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

9.  Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.

Authors:  J D Tissot; P Schneider; J Hauert; M Ruegg; E K Kruithof; F Bachmann
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

10.  Binding and internalization of heparin by vascular smooth muscle cells.

Authors:  J J Castellot; K Wong; B Herman; R L Hoover; D F Albertini; T C Wright; B L Caleb; M J Karnovsky
Journal:  J Cell Physiol       Date:  1985-07       Impact factor: 6.384

View more
  4 in total

1.  Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to α-l-fucosidases from GH29.

Authors:  Chelsea Vickers; Feng Liu; Kento Abe; Orly Salama-Alber; Meredith Jenkins; Christopher M K Springate; John E Burke; Stephen G Withers; Alisdair B Boraston
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

2.  Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells.

Authors:  Jun Ye; Yuping Li; Kiichiro Teruya; Yoshinori Katakura; Akira Ichikawa; Hiroshi Eto; Mutsutaka Hosoi; Masako Hosoi; Shinji Nishimoto; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

Review 3.  Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.

Authors:  Marcel Tutor Ale; Jørn D Mikkelsen; Anne S Meyer
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

Review 4.  Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Authors:  Farzaneh Atashrazm; Ray M Lowenthal; Gregory M Woods; Adele F Holloway; Joanne L Dickinson
Journal:  Mar Drugs       Date:  2015-04-14       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.